Pharmacokinetics of once-daily darunavir/ritonavir in second-line treatment in African children with HIV.
Saved in:
| Title: | Pharmacokinetics of once-daily darunavir/ritonavir in second-line treatment in African children with HIV. |
|---|---|
| Authors: | Tsirizani L; Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, Cape Town, South Africa.; Training and Research Unit of Excellence, Kamuzu University of Health Sciences, Blantyre, Malawi., Mohsenian Naghani S; Department of Pharmacy, Radboudumc Research Institute for Medical Innovation (RIMI), Radboud University Medical Center, Nijmegen, The Netherlands., Waalewijn H; Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, Cape Town, South Africa.; Department of Pharmacy, Radboudumc Research Institute for Medical Innovation (RIMI), Radboud University Medical Center, Nijmegen, The Netherlands., Szubert A; Medical Research Council Clinical Trials Unit at University College London, London, UK., Mulenga V; Department University Teaching Hospital, University of Lusaka, Lusaka, Zambia., Chabala C; Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, Cape Town, South Africa.; Department University Teaching Hospital, University of Lusaka, Lusaka, Zambia., Bwakura-Dangarembizi M; Department of Paediatrics and Child Health, Clinical Research Centre, University of Zimbabwe, Faculty of Medicine and Health Sciences, Harare, Zimbabwe.; Department of Child, Adolescent and Women's Health, University of Zimbabwe Faculty of Medicine and Health Sciences, Harare, Zimbabwe., Chitsamatanga M; Department of Paediatrics and Child Health, Clinical Research Centre, University of Zimbabwe, Faculty of Medicine and Health Sciences, Harare, Zimbabwe., Rutebarika DA; Department of Paediatrics, Joint Clinical Research Centre, Kampala, Uganda., Musiime V; Department of Paediatrics, Joint Clinical Research Centre, Kampala, Uganda.; Department of Paediatrics and Child Health, Makerere University, College of Health Sciences, School of Medicine, Kampala, Uganda., Kasozi M; Department of HIV Reasearch, Joint Clinical Research Centre, Mbarara, Uganda., Lugemwa A; Department of HIV Reasearch, Joint Clinical Research Centre, Mbarara, Uganda., Monkiewicz LN; Medical Research Council Clinical Trials Unit at University College London, London, UK., McIlleron HM; Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, Cape Town, South Africa.; Wellcome Centre for Infectious Diseases Research in Africa (CIDRI-Africa), Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa., Burger DM; Department of Pharmacy, Radboudumc Research Institute for Medical Innovation (RIMI), Radboud University Medical Center, Nijmegen, The Netherlands., Gibb DM; Medical Research Council Clinical Trials Unit at University College London, London, UK., Denti P; Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, Cape Town, South Africa., Wasmann RE; Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, Cape Town, South Africa., Colbers A; Department of Pharmacy, Radboudumc Research Institute for Medical Innovation (RIMI), Radboud University Medical Center, Nijmegen, The Netherlands. |
| Source: | The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2024 Nov 04; Vol. 79 (11), pp. 2990-2998. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't; Randomized Controlled Trial |
| Journal Info: | Publisher: Oxford University Press Country of Publication: England NLM ID: 7513617 Publication Model: Print Cited Medium: Internet ISSN: 1460-2091 (Electronic) Linking ISSN: 03057453 NLM ISO Abbreviation: J Antimicrob Chemother Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1460-2091 |
|---|---|
| DOI: | 10.1093/jac/dkae319 |
